July 24 (Reuters) - Kodiak Sciences KOD.O will abandon further development of its lead drug to treat a type of eye disease after it failed in two late-stage studies, the company said on Monday, ...

Please provide your email address to receive an email when new articles are posted on . Gentex Corp. has announced its acquisition of eSight to develop and manufacture mobile electronic eye wear for ...

June 10 (Reuters) - Skye Bioscience (SKYE.O), opens new tab said on Monday it will discontinue development of its experimental eye disease treatment after the drug failed to meet the main goal of a ...

CHICAGO --- Aerobic glycolysis, the process by which cells transform glucose into lactate, is key for eye development in mammals, according to a new Northwestern Medicine study published in Nature ...

Drug development for neurodegenerative diseases is struggling with one of its most intractable barriers: the slow, variable, and subjective nature of clinical endpoints Traditional assessment scales, ...

A new study from UCLA Health shows that a cardiovascular risk score already used routinely in primary care can predict who will develop serious eye diseases years later. Researchers found that people ...

July 24 (Reuters) - Kodiak Sciences (KOD.O), opens new tab will abandon further development of its lead drug to treat a type of eye disease after it failed in two late-stage studies, the company said ...

Adds shares in paragraph 1, details of trial in paragraphs 2-3 July 24 (Reuters) - Kodiak Sciences Inc KOD.O decided to discontinue development of its experimental drug to treat a type of eye disorder ...